Aggregated electronegative low density lipoprotein in human plasma shows a high tendency toward phospholipolysis and particle fusion

J Biol Chem. 2010 Oct 15;285(42):32425-35. doi: 10.1074/jbc.M110.139691. Epub 2010 Jul 29.

Abstract

Aggregation and fusion of lipoproteins trigger subendothelial retention of cholesterol, promoting atherosclerosis. The tendency of a lipoprotein to form fused particles is considered to be related to its atherogenic potential. We aimed to isolate and characterize aggregated and nonaggregated subfractions of LDL from human plasma, paying special attention to particle fusion mechanisms. Aggregated LDL was almost exclusively found in electronegative LDL (LDL(-)), a minor modified LDL subfraction, but not in native LDL (LDL(+)). The main difference between aggregated (agLDL(-)) and nonaggregated LDL(-) (nagLDL(-)) was a 6-fold increased phospholipase C-like activity in agLDL(-). agLDL(-) promoted the aggregation of LDL(+) and nagLDL(-). Lipoprotein fusion induced by α-chymotrypsin proteolysis was monitored by NMR and visualized by transmission electron microscopy. Particle fusion kinetics was much faster in agLDL(-) than in nagLDL(-) or LDL(+). NMR and chromatographic analysis revealed a rapid and massive phospholipid degradation in agLDL(-) but not in nagLDL(-) or LDL(+). Choline-containing phospholipids were extensively degraded, and ceramide, diacylglycerol, monoacylglycerol, and phosphorylcholine were the main products generated, suggesting the involvement of phospholipase C-like activity. The properties of agLDL(-) suggest that this subfraction plays a major role in atherogenesis by triggering lipoprotein fusion and cholesterol accumulation in the arterial wall.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atherosclerosis / metabolism
  • Cholesterol / chemistry
  • Cholesterol / metabolism*
  • Chymotrypsin / metabolism
  • Humans
  • Lipoproteins, LDL / blood*
  • Lipoproteins, LDL / chemistry*
  • Nuclear Magnetic Resonance, Biomolecular
  • Oxidation-Reduction
  • Particle Size
  • Phospholipids / metabolism*
  • Type C Phospholipases / metabolism

Substances

  • Lipoproteins, LDL
  • Phospholipids
  • Cholesterol
  • Type C Phospholipases
  • Chymotrypsin
  • alpha-chymotrypsin